Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin priming

Eur J Immunol. 1992 Jun;22(6):1365-72. doi: 10.1002/eji.1830220606.

Abstract

In a recent work, we have shown that mycobacterial heat-shock proteins (hsp) of 65-kDa (GroEL-type) and 70-kDa (DnaK-type) acted as carrier molecules in mice, previously primed with Mycobacterium tuberculosis var. bovis (bacillus Calmette-Guérin, BCG), for the induction of high and long-lasting titers of IgG against the repetitive malaria synthetic peptide (NANP)40. Anti-peptide antibodies were induced when the malaria peptide, conjugated to the mycobacterial hsp, was given in the absence of any adjuvants (Lussow et al., Eur. J. Immunol. 1991. 87:2960). In this report, we show that mice immunized with peptides or oligosaccharides conjugated to the 70-kDa hsp produced high titers of IgG antibodies in the absence of any previous priming with BCG. The anti-peptide antibody response persisted for at least 1 year. This adjuvant-free carrier effect of the 70-kDa hsp was T cell dependent, since no anti-peptide nor anti-70-kDa IgG antibodies were induced in athymic nu/nu mice. Previous immunization of mice with the 65-kDa or 70-kDa hsp did not have any negative effect on the induction of anti-peptide IgG antibodies after immunization with hsp-peptide conjugates in the absence of adjuvants. Furthermore, preimmunization with the 65-kDa hsp could substitute for BCG in providing an effective priming for the induction of anti-(NANP) antibodies. Finally, both the 65-kDa and 70-kDa hsp acted as carrier molecules for the induction of IgG antibodies to group C meningococcal oligosaccharides, in the absence of adjuvants. These findings strongly suggest that the use of hsp as carriers in conjugated constructs for the induction of anti-peptide and anti-oligosaccharide antibodies could be of value in the design of new vaccines for eventual use in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antibodies, Protozoan / biosynthesis
  • Antigens, Protozoan / immunology*
  • BCG Vaccine / immunology*
  • Bacterial Proteins
  • Chaperonin 60
  • Chaperonins*
  • Cross Reactions
  • Enzyme-Linked Immunosorbent Assay
  • Glycoconjugates
  • Heat-Shock Proteins / immunology*
  • Immunoglobulin G / biosynthesis
  • Immunotoxins*
  • Malaria / prevention & control*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Inbred CBA
  • Mice, Nude
  • Molecular Sequence Data
  • Polysaccharides, Bacterial / immunology
  • Polysaccharides, Bacterial / isolation & purification
  • Protozoan Proteins*
  • Recombinant Proteins / immunology
  • Time Factors
  • Vaccination / methods*

Substances

  • Antibodies, Protozoan
  • Antigens, Protozoan
  • BCG Vaccine
  • Bacterial Proteins
  • Chaperonin 60
  • Glycoconjugates
  • Heat-Shock Proteins
  • Immunoglobulin G
  • Immunotoxins
  • Polysaccharides, Bacterial
  • Protozoan Proteins
  • Recombinant Proteins
  • circumsporozoite protein, Protozoan
  • heat-shock protein 65, Mycobacterium
  • meningococcal group C polysaccharide
  • CRM197 (non-toxic variant of diphtheria toxin)
  • Chaperonins